Skip to main content

GrafTech International Ltd. (EAF) Stock Forecast

Data as of Aug 7, 2026

Industrials · Current price $7.62 (-0.65%)

Consensus Target
$10.00
Upside
+12.1%
Analysts
4
Rating
Hold(3.25)

Price Target Range

Low $10.00High $10.00

Consensus Price Target Over Time

Analyst Rating Distribution

Last 3 Months

No ratings in the last 3 months.
Strong Buy0
Buy0
Hold0
Sell0
Strong Sell0

6-Month Trend

Latest Analyst Forecasts

Price targets issued by Wall Street analysts. Upside calculated against today's price.

No analyst price targets available.

EAF vs Sector & Market

MetricEAFIndustrials AvgLarge Cap Avg
Analyst Rating3.252.402.42
Analyst Count4818
Target Upside+12.1%+117.9%+17.2%
P/E Ratio-10.6738.7935.26

Revenue Estimates

PeriodLowAvgHigh#
2026-09-30$134M$135M$135M1
2026-12-31$135M$135M$136M1
2027-03-31$137M$138M$139M1
2027-06-30$136M$137M$138M1
2027-09-30$137M$138M$139M1
2027-12-31$137M$138M$139M1

EPS Estimates

PeriodLowAvgHigh#
2026-09-30$-1.17$-1.16$-1.151
2026-12-31$-1.19$-1.18$-1.171
2027-03-31$-1.05$-1.04$-1.031
2027-06-30$-1.01$-1.01$-1.011
2027-09-30$-1.00$-1.00$-1.001
2027-12-31$-0.91$-0.91$-0.901

Frequently Asked Questions

What is the analyst consensus for EAF?

The consensus among 4 analysts covering GrafTech International Ltd. (EAF) is Hold with an average price target of $10.00.

What is the highest price target for EAF?

The highest analyst price target for EAF is $10.00.

What is the lowest price target for EAF?

The lowest analyst price target for EAF is $10.00.

How many analysts cover EAF?

4 analysts have issued ratings for GrafTech International Ltd. in the past 12 months.

Is EAF a buy or sell right now?

Based on 4 analyst ratings, EAF has a consensus rating of Hold (3.25/5) with a +12.1% upside to the consensus target of $10.00.

What are the earnings estimates for EAF?

Analysts estimate EAF will report EPS of $-1.16 for the period ending 2026-09-30, with revenue estimated at $135M.

Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.